SEARCH

SEARCH BY CITATION

References

  • Aoki Y., Sato H., Nishimura N., Takahashi S., Itoh K. and Yamamoto M. (2001) Accelerated DNA adduct formation in the lung of the Nrf2 knockout mouse exposed to diesel exhaust. Toxicol. Appl. Pharmacol. 173, 154160.
  • Aoki Y., Hashimoto A. H., Amanuma K. et al. (2007) Enhanced spontaneous and benzo(a)pyrene-induced mutations in the lung of Nrf2-deficient gpt delta mice. Cancer Res. 67, 56435648.
  • Bagnis A., Izzotti A. and Saccà S. C. (2012) Helicobacter pylori, oxidative stress and glaucoma. Dig. Liver Dis. 44, 963964.
  • Barron M. J., Griffiths P., Turnbull D. M., Bates D. and Nichols P. (2004) The distributions of mitochondria and sodium channels reflect the specific energy requirements and conduction properties of the human optic nerve head. Br. J. Ophthalmol. 88, 286290.
  • Calkins M. J., Jakel R. J., Johnson D. A., Chan K., Kan Y. W. and Johnson J. A. (2005) Protection from mitochondrial complex II inhibition in vitro and in vivo by Nrf2-mediated transcription. Proc. Natl Acad. Sci. USA 102, 244249.
  • Caprioli J., Coleman A. L., Discussion B. F. and   i. G. (2010) Blood pressure, perfusion pressure, and glaucoma. Am. J. Ophthalmol. 149, 704712.
  • Chierzi S., Strettoi E., Cenni M. C. and Maffei L. (1999) Optic nerve crush: axonal responses in wild-type and bcl-2 transgenic mice. J. Neurosci. 19, 83678376.
  • Choi D. H., Cristóvão A. C., Guhathakurta S., Lee J., Joh T. H., Beal M. F. and Kim Y. S. (2012) NADPH oxidase 1-mediated oxidative stress leads to dopamine neuron death in Parkinson's disease. Antioxid. Redox Signal. 16, 10331045.
  • Clements C. M., McNally R. S., Conti B. J., Mak T. W. and Ting J. P. (2006) DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. Proc. Natl Acad. Sci. USA 103, 1509115096.
  • Engin K. N., Yemişci B., Yiğit U., Ağaçhan A. and Coşkun C. (2010) Variability of serum oxidative stress biomarkers relative to biochemical data and clinical parameters of glaucoma patients. Mol. Vis. 16, 12601271.
  • Enomoto A., Itoh K., Nagayoshi E., Haruta J., Kimura T., O'Connor T., Harada T. and Yamamoto M. (2001) High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes. Toxicol. Sci. 59, 169177.
  • Feng Z., Liu Z., Li X., Jia H., Sun L., Tian C., Jia L. and Liu J. (2010) α-Tocopherol is an effective Phase II enzyme inducer: protective effects on acrolein-induced oxidative stress and mitochondrial dysfunction in human retinal pigment epithelial cells. J. Nutr. Biochem. 21, 12221231.
  • Ferreira S. M., Lerner S. F., Brunzini R., Reides C. G., Evelson P. A. and Llesuy S. F. (2010) Time course changes of oxidative stress markers in a rat experimental glaucoma model. Invest. Ophthalmol. Vis. Sci. 51, 46354640.
  • Fischer D., Petkova V., Thanos S. and Benowitz L. I. (2004) Switching mature retinal ganglion cells to a robust growth state in vivo: gene expression and synergy with RhoA inactivation. J. Neurosci. 24, 87268740.
  • Grosskreutz C. L., Hänninen V. A., Pantcheva M. B., Huang W., Poulin N. R. and Dobberfuhl A. P. (2005) FK506 blocks activation of the intrinsic caspase cascade after optic nerve crush. Exp. Eye Res. 80, 681686.
  • Harada T., Harada C., Nakamura K. et al. (2007) The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma. J. Clin. Invest. 117, 17631770.
  • Hayreh S. S. (1997) Factors influencing blood flow in the optic nerve head. J. Glaucoma 6, 412425.
  • Huang W., Fileta J. B., Dobberfuhl A., Filippopolous T., Guo Y., Kwon G. and Grosskreutz C. L. (2005) Calcineurin cleavage is triggered by elevated intraocular pressure, and calcineurin inhibition blocks retinal ganglion cell death in experimental glaucoma. Proc. Natl Acad. Sci. USA 102, 1224212247.
  • Imhoff B. R. and Hansen J. M. (2009) Extracellular redox status regulates Nrf2 activation through mitochondrial reactive oxygen species. Biochem. J. 424, 491500.
  • Inokuchi Y., Imai S., Nakajima Y., Shimazawa M., Aihara M., Araie M. and Hara H. (2009) Edaravone, a free radical scavenger, protects against retinal damage in vitro and in vivo. J. Pharmacol. Exp. Ther. 329, 687698.
  • Inomata Y., Nakamura H., Tanito M., Teratani A., Kawaji T., Kondo N., Yodoi J. and Tanihara H. (2006) Thioredoxin inhibits NMDA-induced neurotoxicity in the rat retina. J. Neurochem. 98, 372385.
  • Itoh K., Chiba T., Takahashi S. et al. (1997) An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun. 236, 313322.
  • Iwase A., Suzuki Y., Araie M. et al. (2004) The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study. Ophthalmology 111, 16411648.
  • Izzotti A., Bagnis A. and Saccà S. C. (2006) The role of oxidative stress in glaucoma. Mutat. Res. 612, 105114.
  • Kerr J., Nelson P. and O'Brien C. (1998) A comparison of ocular blood flow in untreated primary open-angle glaucoma and ocular hypertension. Am. J. Ophthalmol. 126, 4251.
  • Kong L., Tanito M., Huang Z., Li F., Zhou X., Zaharia A., Yodoi J., McGinnis J. F. and Cao W. (2007) Delay of photoreceptor degeneration in tubby mouse by sulforaphane. J. Neurochem. 101, 10411052.
  • Koriyama Y., Chiba K., Yamazaki M., Suzuki H., Muramoto K. and Kato S. (2010) Long-acting genipin derivative protects retinal ganglion cells from oxidative stress models in vitro and in vivo through the Nrf2/antioxidant response element signaling pathway. J. Neurochem. 115, 7991.
  • Lee J., Kannagi M., Ferrante R. J., Kowall N. W. and Ryu H. (2009) Activation of Ets-2 by oxidative stress induces Bcl-xL expression and accounts for glial survival in amyotrophic lateral sclerosis. FASEB J. 23, 17391749.
  • Liby K., Hock T., Yore M. M. et al. (2005) The synthetic triterpenoids, CDDO and CDDO-imidazolide, are potent inducers of heme oxygenase-1 and Nrf2/ARE signaling. Cancer Res. 65, 47894798.
  • Lieven C. J., Hoegger M. J., Schlieve C. R. and Levin L. A. (2006) Retinal ganglion cell axotomy induces an increase in intracellular superoxide anion. Invest. Ophthalmol. Vis. Sci. 47, 14771485.
  • Liu B. and Neufeld A. H. (2001) Nitric oxide synthase-2 in human optic nerve head astrocytes induced by elevated pressure in vitro. Arch. Ophthalmol. 119, 240245.
  • Maher P. and Hanneken A. (2005a) Flavonoids protect retinal ganglion cells from oxidative stress-induced death. Invest. Ophthalmol. Vis. Sci. 46, 47964803.
  • Maher P. and Hanneken A. (2005b) The molecular basis of oxidative stress-induced cell death in an immortalized retinal ganglion cell line. Invest. Ophthalmol. Vis. Sci. 46, 749757.
  • Munemasa Y., Ahn J. H., Kwong J. M., Caprioli J. and Piri N. (2009) Redox proteins thioredoxin 1 and thioredoxin 2 support retinal ganglion cell survival in experimental glaucoma. Gene Ther. 16, 1725.
  • Nagai N., Thimmulappa R. K., Cano M. et al. (2009) Nrf2 is a critical modulator of the innate immune response in a model of uveitis. Free Radic. Biol. Med. 47, 300306.
  • Nakazawa T., Tamai M. and Mori N. (2002a) Brain-derived neurotrophic factor prevents axotomized retinal ganglion cell death through MAPK and PI3K signaling pathways. Invest. Ophthalmol. Vis. Sci. 43, 33193326.
  • Nakazawa T., Tomita H., Yamaguchi K., Sato Y., Shimura M., Kuwahara S. and Tamai M. (2002b) Neuroprotective effect of nipradilol on axotomized rat retinal ganglion cells. Curr. Eye Res. 24, 114122.
  • Nakazawa T., Matsubara A., Noda K. et al. (2006a) Characterization of cytokine responses to retinal detachment in rats. Mol. Vis. 12, 867878.
  • Nakazawa T., Nakazawa C., Matsubara A. et al. (2006b) Tumor necrosis factor-alpha mediates oligodendrocyte death and delayed retinal ganglion cell loss in a mouse model of glaucoma. J. Neurosci. 26, 1263312641.
  • Nakazawa T., Hisatomi T., Nakazawa C. et al. (2007a) Monocyte chemoattractant protein 1 mediates retinal detachment-induced photoreceptor apoptosis. Proc. Natl Acad. Sci. USA 104, 24252430.
  • Nakazawa T., Takahashi H., Nishijima K., Shimura M., Fuse N., Tamai M., Hafezi-Moghadam A. and Nishida K. (2007b) Pitavastatin prevents NMDA-induced retinal ganglion cell death by suppressing leukocyte recruitment. J. Neurochem. 100, 10181031.
  • Neufeld A. H., Sawada A. and Becker B. (1999) Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma. Proc. Natl Acad. Sci. USA 96, 99449948.
  • Osburn W. O. and Kensler T. W. (2008) Nrf2 signaling: an adaptive response pathway for protection against environmental toxic insults. Mutat. Res. 659, 3139.
  • Padmanabhan B., Tong K. I., Ohta T. et al. (2006) Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer. Mol. Cell 21, 689700.
  • Qi X., Lewin A. S., Sun L., Hauswirth W. W. and Guy J. (2007) Suppression of mitochondrial oxidative stress provides long-term neuroprotection in experimental optic neuritis. Invest. Ophthalmol. Vis. Sci. 48, 681691.
  • Quigley H. A. (1996) Number of people with glaucoma worldwide. Br. J. Ophthalmol. 80, 389393.
  • Ramamoorthy M., Sykora P., Scheibye-Knudsen M., Dunn C., Kasmer C., Zhang Y., Becker K. G., Croteau D. L. and Bohr V. A. (2012) Sporadic Alzheimer disease fibroblasts display an oxidative stress phenotype. Free Radic. Biol. Med. 53, 13711380.
  • Ryu M., Yasuda M., Shi D. et al. (2012) Critical role of calpain in axonal damage-induced retinal ganglion cell death. J. Neurosci. Res. 90, 802815.
  • Salido E. M., de Zavalía N., Schreier L., De Laurentiis A., Rettori V., Chianelli M., Keller Sarmiento M. I., Arias P. and Rosenstein R. E. (2012) Retinal changes in an experimental model of early type 2 diabetes in rats characterized by non-fasting hyperglycemia. Exp. Neurol. 236, 151160.
  • Satoh T., Okamoto S. I., Cui J., Watanabe Y., Furuta K., Suzuki M., Tohyama K. and Lipton S. A. (2006) Activation of the Keap1/Nrf2 pathway for neuroprotection by electrophilic [correction of electrophillic] phase II inducers. Proc. Natl Acad. Sci. USA 103, 768773.
  • Seki M. and Lipton S. A. (2008) Targeting excitotoxic/free radical signaling pathways for therapeutic intervention in glaucoma. Prog. Brain Res. 173, 495510.
  • Shanab A. Y., Nakazawa T., Ryu M. et al. (2012) Metabolic stress response implicated in diabetic retinopathy: the role of calpain, and the therapeutic impact of calpain inhibitor. Neurobiol. Dis. 48, 556567.
  • Shareef S., Sawada A. and Neufeld A. H. (1999) Isoforms of nitric oxide synthase in the optic nerves of rat eyes with chronic moderately elevated intraocular pressure. Invest. Ophthalmol. Vis. Sci. 40, 28842891.
  • Shih A. Y., Imbeault S., Barakauskas V., Erb H., Jiang L., Li P. and Murphy T. H. (2005) Induction of the Nrf2-driven antioxidant response confers neuroprotection during mitochondrial stress in vivo. J. Biol. Chem. 280, 2292522936.
  • Singh A., Misra V., Thimmulappa R. K. et al. (2006) Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer. PLoS Med. 3, e420.
  • Sullivan R. K., Woldemussie E., Macnab L., Ruiz G. and Pow D. V. (2006) Evoked expression of the glutamate transporter GLT-1c in retinal ganglion cells in human glaucoma and in a rat model. Invest. Ophthalmol. Vis. Sci. 47, 38533859.
  • Tanito M., Agbaga M. P. and Anderson R. E. (2007) Upregulation of thioredoxin system via Nrf2-antioxidant responsive element pathway in adaptive-retinal neuroprotection in vivo and in vitro. Free Radic. Biol. Med. 42, 18381850.
  • Uno K., Prow T. W., Bhutto I. A., Yerrapureddy A., McLeod D. S., Yamamoto M., Reddy S. P. and Lutty G. A. (2010) Role of Nrf2 in retinal vascular development and the vaso-obliterative phase of oxygen-induced retinopathy. Exp. Eye Res. 90, 493500.
  • Vargas M. R., Johnson D. A., Sirkis D. W., Messing A. and Johnson J. A. (2008) Nrf2 activation in astrocytes protects against neurodegeneration in mouse models of familial amyotrophic lateral sclerosis. J. Neurosci. 28, 1357413581.
  • Vorwerk C. K., Gorla M. S. and Dreyer E. B. (1999) An experimental basis for implicating excitotoxicity in glaucomatous optic neuropathy. Surv. Ophthalmol. 43(Suppl 1), S142S150.
  • Yücel Y. H., Zhang Q., Weinreb R. N., Kaufman P. L. and Gupta N. (2003) Effects of retinal ganglion cell loss on magno-, parvo-, koniocellular pathways in the lateral geniculate nucleus and visual cortex in glaucoma. Prog. Retin. Eye Res. 22, 465481.
  • Zhao Z., Chen Y., Wang J., Sternberg P., Freeman M. L., Grossniklaus H. E. and Cai J. (2011) Age-related retinopathy in NRF2-deficient mice. PLoS ONE 6, e19456.